Osteoporosis & Hip Fractures in Geriatrics — MRCP Part 1
- Crack Medicine

- 2 hours ago
- 3 min read
TL;DR:
Osteoporosis and hip fractures are high-yield, cross-disciplinary topics in MRCP Part 1. Examiners focus on diagnostic criteria, when treatment is mandatory without DXA, hip-fracture anatomy and complications, and first-line therapy in older adults. Master the principles, avoid common traps, and practise exam-style reasoning to score reliably.
Why this topic matters for MRCP candidates
Osteoporosis is common, often silent, and clinically devastating when it culminates in hip fracture. In geriatrics, a hip fracture is not just an orthopaedic event—it predicts loss of independence and a 1-year mortality approaching 20–30%. For MRCP Part 1, this topic is repeatedly tested because it integrates geriatrics, endocrinology, orthopaedics, and preventive medicine.
For syllabus alignment, see the official MRCP(UK) blueprint and the NICE osteoporosis guidance (CG146).
Scope and what examiners expect
You should be confident with:
Diagnostic thresholds and when DXA is not required
Fragility fractures and automatic treatment indications
Hip fracture anatomy and key complications
Risk factors (including secondary osteoporosis)
Evidence-based first-line management in older adults
Core high-yield principles (exam favourites)
1) Osteoporosis: definition vs diagnosis
Definition: DXA T-score ≤ –2.5.
Clinical diagnosis: A low-trauma hip or vertebral fracture is diagnostic of osteoporosis regardless of DXA. This is a classic MRCP trap.
2) Fragility fractures mandate treatment
A fracture from a fall at standing height (or less) confers high future risk. In older adults, treatment should start without waiting for DXA or FRAX.
3) Hip fractures are anatomically distinct
Intracapsular (neck of femur): risk of avascular necrosis, non-union.
Extracapsular (intertrochanteric/subtrochanteric): greater blood loss, different fixation.Anatomy predicts complications and management priorities.
4) FRAX supports—but does not override—clinical judgement
FRAX estimates 10-year fracture risk but does not apply after a proven fragility fracture. Over-reliance on FRAX is commonly tested as a wrong answer.
5) First-line pharmacology
Bisphosphonates (e.g., alendronate) are first line.
Ensure adequate calcium and vitamin D.
Consider alternatives (e.g., denosumab) if oral bisphosphonates are unsuitable.
6) Steroid-induced osteoporosis
≥3 months of systemic glucocorticoids markedly increases fracture risk.
Bone loss is early and dose-dependent—prophylaxis matters.
7) Osteoporosis in men
Often under-recognised; causes include steroids, hypogonadism, alcohol excess. Hip fractures in men carry higher mortality.
8) Falls prevention is part of treatment
Vision, postural hypotension, sedatives, and environmental hazards must be addressed. Exams reward holistic answers.
The five most tested subtopics
DXA thresholds: T-score vs Z-score; who needs which.
Secondary causes: steroids, hyperthyroidism, myeloma, malabsorption, CKD.
Hip fracture anatomy: intracapsular vs extracapsular implications.
Initial management: analgesia, early surgery, thromboprophylaxis, pressure-area care.
Drug hierarchy: bisphosphonates first; alternatives when contraindicated.
Key differences at a glance
Feature | Osteoporosis | Hip fracture |
Nature | Chronic metabolic bone disease | Acute consequence |
Diagnosis | DXA T-score ≤ –2.5 or clinical | Clinical + imaging |
Exam focus | Criteria, prevention, risk | Anatomy, complications |
Management | Long-term pharmacological | Surgical + rehab |
Prognosis | Preventable progression | High short-term mortality |
Mini-case (exam style)
A 79-year-old woman falls from standing height and sustains an intertrochanteric fracture. DXA has not yet been performed. What is the most appropriate next step regarding bone health?
A. Await DXA before starting treatmentB. Start calcium aloneC. Start a bisphosphonateD. Calculate FRAX scoreE. Review in six months
Correct answer: C.A low-trauma hip fracture is diagnostic of osteoporosis. Treatment should begin without waiting for DXA or FRAX.

Common pitfalls (remember these)
Waiting for DXA after a fragility hip fracture
Confusing T-score with Z-score
Assuming FRAX guides post-fracture treatment
Forgetting steroid-induced osteoporosis
Ignoring falls assessment in management
Practical study checklist (last-week revision)
□ Memorise DXA thresholds and indications
□ Distinguish hip fracture types and complications
□ Revise steroid-related scenarios
□ Know bisphosphonate contraindications
□ Link falls → fractures → mortality
FAQs
Is DXA mandatory after a hip fracture?
No. A low-trauma hip fracture is diagnostic of osteoporosis and warrants treatment regardless of DXA.
Which drug is most tested for osteoporosis in MRCP Part 1?
Oral bisphosphonates (especially alendronate), including prerequisites and contraindications.
Does FRAX apply after a fragility fracture?
No. FRAX estimates risk in patients without established fragility fractures.
Why are hip fractures such a high-yield geriatric topic?
They combine anatomy, acute care, chronic disease, and mortality—ideal for integrated exam questions.
Ready to start?
MRCP Part 1 overview: https://crackmedicine.com/mrcp-part-1/
Free MRCP MCQs: https://crackmedicine.com/qbank/
Start a mock test: https://crackmedicine.com/mock-tests/
Focused video lectures: https://crackmedicine.com/lectures/
Sources
NICE. Osteoporosis: assessing the risk of fragility fracture (CG146). https://www.nice.org.uk/guidance/cg146
NICE. Hip fracture management. https://www.nice.org.uk/guidance/cg124
MRCP(UK) Examination Syllabus. https://www.mrcpuk.org/mrcpuk-examinations/syllabuses



Comments